Solid Logix focuses on enabling scientific discovery and promoting biotechnology through innovative software and data-driven solutions. Our expertise bridges the gap between complicated biological difficulties and transformative insights, assisting enterprises in achieving ground-breaking outcomes.
We’ve developed expertise across key areas, enabling us to deliver innovative solutions with rapid and impactful results.
Unlock the power of complex datasets with customized analytics and visualizations.
Empowering advancements in genomics and proteomics with tailored tools.
Streamline workflows with advanced automation technologies.
Developing solutions for personalized healthcare initiatives.
Create robust software systems to support biotech organizations in innovation, efficiency, and growth.
Delivering software solutions to accelerate research, streamline data analysis, and facilitate breakthroughs that shape the future of biotechnology.
When exploring novel questions about fundamental biology, health, and disease, our researchers sometimes encounter challenges where the necessary tools are unavailable. In such instances, we innovate by creating new tools or adapting existing ones to enable groundbreaking discoveries.
We employ agile cycles to quickly prototype and test bioinformatics tools, incorporating feedback from researchers and end-users at every stage. This ensures tools are fine-tuned to meet scientific needs efficiently, reducing the time from concept to impactful discovery.
Our approach prioritizes the use of AI/ML algorithms, high-performance computing, and cloud-native solutions tailored for biotech challenges. This allows us to process and analyze complex biological data at scale, enabling breakthroughs in areas like precision medicine, genomics, and epidemiology.
We emphasize automating complex bioinformatics workflows, such as sequencing analysis or molecular modeling. By reducing manual intervention, we minimize errors and free researchers to focus on generating insights, ultimately accelerating the pace of discovery and innovation.
Leveraging our expertise, we’ve driven meaningful advancements in these key areas, delivering impactful results and shaping the future of science, technology, and innovation.
Advancing the understanding of genetic variation and disease through innovative bioinformatics solutions.
Supporting public health initiatives with real-time data insights and monitoring tools.
Enhancing clinical research with advanced analytics and streamlined data integration.
Accelerating pharmaceutical innovation with advanced data analysis and precision medicine solutions.
Developing innovative solutions to improve crop resilience and agricultural productivity.
Leveraging genomics to create targeted therapies and improve patient outcomes.
Solid Logix has consistently embraced innovation to remain at the forefront of the rapidly advancing biotech industry. By integrating cutting-edge technologies like AI-driven data analysis, high-performance computing, and cloud-based solutions, we empower researchers and organizations to tackle complex challenges. Our commitment to continuous learning and collaboration with industry leaders ensures that we stay ahead of emerging trends, delivering software solutions that drive breakthroughs in healthcare, bioinformatics, and life sciences. Solid Logix doesn’t just adapt to change—we lead it, providing tools that accelerate progress and transform possibilities into realities.
The Human Genome Project, which began in 1990, produced a "draft" human genome sequence over a 15-month period from April 1999 to June 2000. The estimated cost for generating that initial "draft" was approximately $300 million worldwide.
Source: National Human Genome Research InstituteThe introduction of next-generation sequencing technologies reduced both the time and cost of sequencing. By 2008, sequencing a human genome using these technologies cost only a few hundred dollars, a significant decrease from earlier years.
Source: National Human Genome Research InstituteTechnological advancements continued to accelerate sequencing capabilities. By the mid-2010s, sequencing a human genome could be completed in a matter of days.
With the advent of third-generation sequencing technologies, such as Oxford Nanopore and PacBio, sequencing times have further decreased. As of 2024, sequencing a human genome can be accomplished in less than a day, with some technologies achieving this in just a few hours.
These advancements have not only reduced sequencing times but also significantly lowered costs, making genomic sequencing more accessible for research and clinical applications.
Note: The specific timeframes mentioned are approximate and can vary based on the sequencing technology and protocols used.